The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2023

Filed:

Aug. 09, 2017
Applicant:

Turnstone Limited Partnership, Toronto, CA;

Inventors:

Almohanad Alkayyal, Ottawa, CA;

Rebecca Auer, Ottawa, CA;

John Cameron Bell, Ottawa, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/766 (2015.01); A61K 9/00 (2006.01); C12N 5/10 (2006.01); C07K 14/145 (2006.01); C12N 15/86 (2006.01); A61K 38/20 (2006.01); A61P 35/00 (2006.01); C07K 14/54 (2006.01); A61K 35/768 (2015.01);
U.S. Cl.
CPC ...
A61K 35/766 (2013.01); A61K 9/0019 (2013.01); A61K 35/768 (2013.01); A61K 38/20 (2013.01); A61K 38/208 (2013.01); A61P 35/00 (2018.01); C07K 14/145 (2013.01); C07K 14/54 (2013.01); C07K 14/5434 (2013.01); C12N 5/10 (2013.01); C12N 15/86 (2013.01); C12N 2760/20041 (2013.01); C12N 2760/20232 (2013.01); C12N 2760/20243 (2013.01);
Abstract

Disclosed herein is an oncolytic recombinant Maraba virus whose genome comprises one or more nucleic acid sequences that, in combination, encode an interleukin-12 (IL12) protein or a functional portion thereof. A method for treating a cancer in a patient using the oncolytic recombinant Maraba virus is also disclosed. The present disclosure also provides a tumour cell infected with an oncolytic rhabdovirus whose genome comprises one or more nucleic acid sequences that, in combination, encode an interleukin-12 (IL12) protein or a functional portion thereof, for use as an infected cell vaccine (ICV) for the treatment of a cancer. A method for treating a cancer in a patient using the infected cell vaccine is also disclosed.


Find Patent Forward Citations

Loading…